114 related articles for article (PubMed ID: 32277689)
41. Structural and regulatory aspects of enzymes in chemotherapy.
Handschumacher RE
Cancer Res; 1969 Dec; 29(12):2466-8. PubMed ID: 4313006
[No Abstract] [Full Text] [Related]
42. Synergistic anti-tumor efficacy of doxorubicin and flavopiridol in an in vivo hepatocellular carcinoma model.
Kwak MS; Yu SJ; Yoon JH; Lee SH; Lee SM; Lee JH; Kim YJ; Lee HS; Kim CY
J Cancer Res Clin Oncol; 2015 Nov; 141(11):2037-45. PubMed ID: 25989942
[TBL] [Abstract][Full Text] [Related]
43. Dryocrassin ABBA Induces Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells Through a Caspase-Dependent Mitochondrial Pathway.
Jin Z; Wang WF; Huang JP; Wang HM; Ju HX; Chang Y
Asian Pac J Cancer Prev; 2016; 17(4):1823-8. PubMed ID: 27221859
[TBL] [Abstract][Full Text] [Related]
44. CHM-1, a novel synthetic quinolone with potent and selective antimitotic antitumor activity against human hepatocellular carcinoma in vitro and in vivo.
Wang SW; Pan SL; Huang YC; Guh JH; Chiang PC; Huang DY; Kuo SC; Lee KH; Teng CM
Mol Cancer Ther; 2008 Feb; 7(2):350-60. PubMed ID: 18281518
[TBL] [Abstract][Full Text] [Related]
45. Chemopreventive allylthiopyridazine derivatives induce apoptosis in SK-Hep-1 hepatocarcinoma cells through a caspase-3-dependent mechanism.
Jung MY; Kwon SK; Moon A
Eur J Cancer; 2001 Nov; 37(16):2104-10. PubMed ID: 11597391
[TBL] [Abstract][Full Text] [Related]
46. Enhancement of cytotoxic and pro-apoptotic effects of 2-aminophenoxazine-3-one on the rat hepatocellular carcinoma cell line dRLh-84, the human hepatocellular carcinoma cell line HepG2, and the rat normal hepatocellular cell line RLN-10 in combination with 2-deoxy-D-glucose.
Takemura A; Che XF; Tabuchi T; Moriya S; Miyazawa K; Tomoda A
Oncol Rep; 2012 Feb; 27(2):347-55. PubMed ID: 22076586
[TBL] [Abstract][Full Text] [Related]
47. [Effects of NK-104 on apoptosis and caspase-3 activity in hepatocellular carcinoma cells].
Wang JY; Xu ZY
Zhong Xi Yi Jie He Xue Bao; 2007 May; 5(3):298-301. PubMed ID: 17498490
[TBL] [Abstract][Full Text] [Related]
48. FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling.
Hung JH; Lu YS; Wang YC; Ma YH; Wang DS; Kulp SK; Muthusamy N; Byrd JC; Cheng AL; Chen CS
Cancer Res; 2008 Feb; 68(4):1204-12. PubMed ID: 18281497
[TBL] [Abstract][Full Text] [Related]
49. Synergistic cytotoxicity of the poly (ADP-ribose) polymerase inhibitor ABT-888 and temozolomide in dual-drug targeted magnetic nanoparticles.
Muñoz-Gámez JA; López Viota J; Barrientos A; Carazo Á; Sanjuán-Nuñez L; Quiles-Perez R; Muñoz-de-Rueda P; Delgado Á; Ruiz-Extremera Á; Salmerón J
Liver Int; 2015 Apr; 35(4):1430-41. PubMed ID: 24821649
[TBL] [Abstract][Full Text] [Related]
50. beta-Ionone enhances TRAIL-induced apoptosis in hepatocellular carcinoma cells through Sp1-dependent upregulation of DR5 and downregulation of NF-kappaB activity.
Kim MO; Moon DO; Kang CH; Kwon TK; Choi YH; Kim GY
Mol Cancer Ther; 2010 Apr; 9(4):833-43. PubMed ID: 20354117
[TBL] [Abstract][Full Text] [Related]
51. Upregulation of Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Mediates the Reversal Effect of Verapamil on Chemo-Resistance to Adriamycin of Hepatocellular Carcinoma.
Yang G; Fan G; Zhang T; Ma K; Huang J; Liu M; Teng X; Xu K; Fan P; Cheng D
Med Sci Monit; 2018 Apr; 24():2072-2082. PubMed ID: 29627846
[TBL] [Abstract][Full Text] [Related]
52. The insulin-like growth factor-I receptor inhibitor picropodophyllin-induced selective apoptosis of hepatocellular carcinoma cell through a caspase-dependent mitochondrial pathway.
E C; Li J; Shao D; Zhang D; Pan Y; Chen L; Zhang X
Oncol Res; 2013; 21(2):103-10. PubMed ID: 24406046
[TBL] [Abstract][Full Text] [Related]
53. Mitochondrial-dependent caspase activation pathway is involved in baicalein-induced apoptosis in human hepatoma J5 cells.
Kuo HM; Tsai HC; Lin YL; Yang JS; Huang AC; Yang MD; Hsu SC; Chung MC; Gibson Wood W; Chung JG
Int J Oncol; 2009 Oct; 35(4):717-24. PubMed ID: 19724907
[TBL] [Abstract][Full Text] [Related]
54. Anticancer activity of an antisense oligonucleotide targeting TRADD combined with proteasome inhibitors in chemoresistant hepatocellular carcinoma cells.
Witort E; Lulli M; Carloni V; Capaccioli S
J Chemother; 2013 Oct; 25(5):292-7. PubMed ID: 24070137
[TBL] [Abstract][Full Text] [Related]
55. Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma.
Chen J; Jin R; Zhao J; Liu J; Ying H; Yan H; Zhou S; Liang Y; Huang D; Liang X; Yu H; Lin H; Cai X
Cancer Lett; 2015 Oct; 367(1):1-11. PubMed ID: 26170167
[TBL] [Abstract][Full Text] [Related]
56. [Treatment of progressive non-resectable hepatoma].
Tanikawa K; Tanaka M
Nihon Naika Gakkai Zasshi; 1994 Sep; 83(9):1562-5. PubMed ID: 7798750
[No Abstract] [Full Text] [Related]
57. FHL1 and Smad4 synergistically inhibit vascular endothelial growth factor expression.
Zhou Z; Lu J; Dou J; Lv Z; Qin X; Lin J
Mol Med Rep; 2013 Feb; 7(2):649-53. PubMed ID: 23184087
[TBL] [Abstract][Full Text] [Related]
58. Hydrogen peroxide inducible clone-5 mediates reactive oxygen species signaling for hepatocellular carcinoma progression.
Wu JR; Hu CT; You RI; Pan SM; Cheng CC; Lee MC; Wu CC; Chang YJ; Lin SC; Chen CS; Lin TY; Wu WS
Oncotarget; 2015 Oct; 6(32):32526-44. PubMed ID: 26416447
[TBL] [Abstract][Full Text] [Related]
59. Novel strategies for hepatocellular carcinoma based on MMPs science.
Okazaki I; Inagaki Y
Anticancer Agents Med Chem; 2012 Sep; 12(7):753-63. PubMed ID: 22292750
[TBL] [Abstract][Full Text] [Related]
60. Pan-cancer analysis of the CASP gene family in relation to survival, tumor-infiltrating immune cells and therapeutic targets.
Hong W; Gu Y; Guan R; Xie D; Zhou H; Yu M
Genomics; 2020 Nov; 112(6):4304-4315. PubMed ID: 32682809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
